← Back to Search

Other

Dry Eye Drink for Dry Eye Syndrome

N/A
Waitlist Available
Research Sponsored by Bruder Healthcare
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male and/or female subjects aged between 18 and 65 years (both limits inclusive)
Subjects with symptomatic Dry Eye Syndrome confirmed at baseline in at least any one or both the eyes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 0 and day 30
Awards & highlights

Study Summary

This trial tested the effect of a special eye drink on reducing eye dryness.

Who is the study for?
This trial is for men and women aged 18-65 with Dry Eye Syndrome, confirmed by specific tests (MMP-9 and tear osmolarity) and a self-reported questionnaire. Participants must be able to give consent and follow the study plan. Pregnant or nursing individuals, recent eye surgery patients, those with ocular infections or unstable systemic diseases, participants in other studies within the last month, illiterate individuals who can't keep a diary, people allergic to drink ingredients or with certain eyelid/ocular conditions are excluded.Check my eligibility
What is being tested?
The study is testing the 'Dry Eye Drink' on its ability to hydrate and improve symptoms of dryness in eyes affected by Dry Eye Syndrome. It's an observational study where subjects consume the drink and report changes in their condition.See study design
What are the potential side effects?
While not explicitly stated here, potential side effects may include discomfort from taste or gastrointestinal issues due to new dietary components introduced by the 'Dry Eye Drink'.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.
Select...
I have been diagnosed with Dry Eye Syndrome in at least one eye.
Select...
My test for MMP-9 was positive.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 0 and day 30
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 0 and day 30 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change on the SPEED score
Secondary outcome measures
Change in MMP-9 levels
Change in Tear Osmolarity

Trial Design

1Treatment groups
Experimental Treatment
Group I: Dry Eye DrinkExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

CBCC Global ResearchNETWORK
7 Previous Clinical Trials
1,223 Total Patients Enrolled
Bruder HealthcareLead Sponsor

Media Library

Dry Eye Drink (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05949697 — N/A
Dry Eye Syndrome Research Study Groups: Dry Eye Drink
Dry Eye Syndrome Clinical Trial 2023: Dry Eye Drink Highlights & Side Effects. Trial Name: NCT05949697 — N/A
Dry Eye Drink (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05949697 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I have the eligibility criteria to join this clinical investigation?

"Patients with dry eye syndrome who are aged between 18 and 65 can apply to be part of this study, which is aiming to recruit 60 people in total."

Answered by AI

Does this research project permit participation of geriatric patients?

"Patients must meet the following age criteria to be accepted into this trial: 18 years old or above, and 65 years old or below."

Answered by AI

Is it feasible to register for this clinical experiment presently?

"Clinicaltrials.gov data indicates that, while this trial went online on July 1st 2023 and was last modified a week later, it is not currently in search of participants. However, 90 other studies are actively recruiting patients right now."

Answered by AI
~34 spots leftby Apr 2025